Uni Thera M Advanced

Drug Index

A multivitamin is a preparation intended to serve as a dietary supplement with vitamins, dietary minerals, and other nutritional elements. Such preparations are available in the form of tablets, capsules, pastilles, powders, liquids, or injectable formulations. Other than injectable formulations, which are only available and administered under medical supervision, multivitamins are recognized by the Codex Alimentarius Commission (the United Nations' authority on food standards) as a category ...

Drug Index

Abemaciclib (trade names Verzenio, Verzenios and Ramiven) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[1] It was designated as a breakthrough therapy for breast cancer by the U.S. Food and Drug Administration (FDA) in October 2015.[2] On 28 September 2017, it was approved for use in the United States by the FDA for the treatment of certain breast ...

Abemaciclib

Abemaciclib (trade names Verzenio, Verzenios and Ramiven) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[1] It was designated as a breakthrough therapy for breast cancer by the U.S. Food and Drug Administration (FDA) in October 2015.[2] On 28 September 2017, it was approved for use in the United States by the FDA for the treatment of certain breast ...

Hi, Sorry for my English but as the knowledge of this medicin is more advanced in the United States, I prefer ask my question here. My friend has a secundary breast cancer ( now it went to her liver ) and my question is, if Tykerb is so bad for the liver how come that her doctor prescribed Tykerb ? Any answer to what are her chances ? Many thanks. Martine ## Tykerb is for solid tumours such as breast cancer. During development it was known as a small molecule. Patients who meet specific indication criteria may be prescribed Tykerb as part of combination therapy for breast cancer. Pharmacologically, lapatinib is a dual tyrosine kinase inhibitor that interrupts cancer-causing cellular signals. I am unable to determine your friends reaction or positive treatment to the drug, due to the fac...

1 REPLY